Breaking News

Teva-KOWA Pharma Co. To Acquire Taisho Pharma

Teva-KOWA Pharma Co., Ltd. has signed a definitive agreement to acquire a majority (at least 66.7%) of the outstanding shares of Taisho Pharmaceutical Industries, Ltd.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Teva-KOWA Pharma Co., Ltd., a joint venture in Japan between Teva Pharmaceutical Industries, Ltd. and KOWA Co., Ltd., has signed a definitive agreement to acquire a majority (at least 66.7%) of the outstanding shares of Taisho Pharmaceutical Industries, Ltd. The transaction is expected to close by the end of the year. Financial terms were not disclosed. Taisho manufactures and markets more than 200 generic products to pharmacies, clinics, hospitals and wholesalers. Taisho also has a finished ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters